Literature DB >> 2900014

Intra-cerebral cysteamine infusions attenuate the motor response to dopaminergic agonists.

N Lee1, J M Radke, S R Vincent.   

Abstract

Previous studies have suggested that somatostatin neurons in the basal ganglia may be involved in motor activity. In the present experiments, the effects of cysteamine, a drug which reduces somatostatin levels, on the basal and dopamine-mediated motor activities were examined in the rat. Neither intra-striatal nor intra-accumbens infusions of cysteamine had any effect on motor activity prior to the administration of dopamine agonists. However, intra-striatal cysteamine infusions reduced the duration of the stereotypic behavior induced by systemic apomorphine. In addition, intra-accumbens infusions of cysteamine produced a slight reduction in the locomotor response induced by amphetamine. The direct intra-cerebral infusion of cysteamine produced a significant depletion in the levels of somatostatin at the site of injections as measured by radioimmunoassay. These results indicate that somatostatin neurons in the basal ganglia may modulate the motor responses following dopaminergic activation, and further support the presence of a dopamine-somatostatin interaction in this region.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900014     DOI: 10.1016/0166-4328(88)90065-4

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  3 in total

1.  Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats.

Authors:  Svetlana Semenova; Daniel Hoyer; Mark A Geyer; Athina Markou
Journal:  Neuropeptides       Date:  2010-10       Impact factor: 3.286

2.  Somatostatin antagonist induces catalepsy in the aged rat.

Authors:  Ilya D Ionov; Irina I Pushinskaya
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.415

3.  Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor.

Authors:  K Kaupmann; C Bruns; F Raulf; H P Weber; H Mattes; H Lübbert
Journal:  EMBO J       Date:  1995-02-15       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.